Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3995)
All Articles published online
|
Aug 28, 2005 (publication date) through Jan 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boonla C, Sripa B, Thuwajit P, Cha-On U, Puapairoj A, Miwa M, Wongkham S. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2005; 11(32): 4939-4946 [PMID: 16124042 DOI: 10.3748/wjg.v11.i32.4939] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i32/4939.htm |
| Number | Citing Articles |
| 1 |
Alphonse E. Sirica, Catherine I. Dumur, Deanna J.W. Campbell, Jorge A. Almenara, Olorunseun O. Ogunwobi, Jennifer L. Dewitt. Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic Mechanisms. Clinical Gastroenterology and Hepatology 2009; 7(11): S68 doi: 10.1016/j.cgh.2009.08.023
|
| 2 |
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma. 2021; : 527 doi: 10.1007/978-3-030-70936-5_25
|
| 3 |
Noel Pabalan, Sutawadee Sukcharoensin, Kritiya Butthongkomvong, Hamdi Jarjanazi, Veerachai Thitapakorn. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis. Journal of Gastrointestinal Cancer 2019; 50(1): 54 doi: 10.1007/s12029-017-0032-9
|
| 4 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
| 5 |
Atit Silsirivanit, Norie Araki, Chaisiri Wongkham, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Kazuhiko Kuwahara, Yoshiki Narimatsu, Hiromichi Sawaki, Hisashi Narimatsu, Seiji Okada, Nobuo Sakaguchi, Sopit Wongkham. CA‐S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Science 2013; 104(10): 1278 doi: 10.1111/cas.12222
|
| 6 |
Yu-Chan Chang, Ming-Huang Chen, Chun-Nan Yeh, Michael Hsiao. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 2020; 10(10): 1377 doi: 10.3390/biom10101377
|
| 7 |
Terry Lok, Lihong Chen, Fan Lin, Hanlin L. Wang. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Human Pathology 2014; 45(2): 394 doi: 10.1016/j.humpath.2013.10.004
|
| 8 |
Ji Xuan, Jing Li, Zhirui Zhou, Renrong Zhou, Huabing Xu, Wei Wen. The diagnostic performance of serum MUC5AC for cholangiocarcinoma. Medicine 2016; 95(24): e3513 doi: 10.1097/MD.0000000000003513
|
| 9 |
Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, Sopit Wongkham. Prognostic biomarkers for cholangiocarcinoma and their clinical implications. Expert Review of Anticancer Therapy 2018; 18(6): 579 doi: 10.1080/14737140.2018.1467760
|
| 10 |
Juthamas Khiaowichit, Chutima Talabnin, Chavaboon Dechsukhum, Atit Silsirivanit, Krajang Talabnin. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways. Life 2022; 12(2): 174 doi: 10.3390/life12020174
|
| 11 |
Mukulika Bose, Pinku Mukherjee. Microbe–MUC1 Crosstalk in Cancer-Associated Infections. Trends in Molecular Medicine 2020; 26(3): 324 doi: 10.1016/j.molmed.2019.10.003
|
| 12 |
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic review. European Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
|
| 13 |
Zachary J. Brown, D. Brock Hewitt, Timothy M. Pawlik. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy. Frontiers in Bioscience-Landmark 2022; 27(3) doi: 10.31083/j.fbl2703085
|
| 14 |
Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon, Thaweesak Chieochansin, Mutita Junking, Pa-thai Yenchitsomanus. Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells. Cytotherapy 2023; 25(2): 148 doi: 10.1016/j.jcyt.2022.10.006
|
| 15 |
Boris R.A. Blechacz, Gregory J. Gores. Molecular Genetics of Liver Neoplasia. 2010; : 75 doi: 10.1007/978-1-4419-6082-5_5
|
| 16 |
Zengwei Tang, Yuan Yang, Xiaolu Wang, Wenbo Meng, Xun Li. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma. BMJ Open 2019; 9(1): e021693 doi: 10.1136/bmjopen-2018-021693
|
| 17 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
|
| 18 |
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales, Guido Carpino. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022; : gutjnl-2022-327099 doi: 10.1136/gutjnl-2022-327099
|
| 19 |
M M Aloysius, A M Zaitoun, S Awad, M Ilyas, B J Rowlands, D N Lobo. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. British Journal of Surgery 2010; 97(8): 1269 doi: 10.1002/bjs.7107
|
| 20 |
Kanlayanee Sawanyawisuth, Atit Silsirivanit, Kunlathida Kunlabut, Nattawat Tantapotinan, Kulthida Vaeteewoottacharn, Sopit Wongkham. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: A potential marker for early diagnosis. Parasitology International 2012; 61(1): 151 doi: 10.1016/j.parint.2011.07.013
|
| 21 |
Peti Thuwajit, Watinee Chawengrattanachot, Chanitra Thuwajit, Banchob Sripa, Anucha Paupairoj, Siri Chau‐in. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival. Journal of Gastroenterology and Hepatology 2008; 23(5): 771 doi: 10.1111/j.1440-1746.2008.05332.x
|
| 22 |
Marutpong Detarya, Kanlayanee Sawanyawisuth, Chaiwat Aphivatanasiri, Sriwipa Chuangchaiya, Paksiree Saranaruk, Lukkana Sukprasert, Atit Silsirivanit, Norie Araki, Sopit Wongkham, Chaisiri Wongkham. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. Glycobiology 2020; 30(5): 312 doi: 10.1093/glycob/cwz098
|
| 23 |
Urvi A. Shah, Amara G. Nandikolla, Lakshmi Rajdev. Immunotherapeutic Approaches to Biliary Cancer. Current Treatment Options in Oncology 2017; 18(7) doi: 10.1007/s11864-017-0486-9
|
| 24 |
Natini Jinawath, Yaovalux Chamgramol, Yoichi Furukawa, Kazutaka Obama, Tatsuhiko Tsunoda, Banchob Sripa, Chawalit Pairojkul, Yusuke Nakamura. Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma†. Hepatology 2006; 44(4): 1025 doi: 10.1002/hep.21330
|
| 25 |
Kenji Mimatsu, Takatsugu Oida, Atsushi Kawasaki, Hisao Kano, Nobutada Fukino, Kazutoshi Kida, Youichi Kuboi, Sadao Amano. Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case. Surgery Today 2011; 41(10): 1410 doi: 10.1007/s00595-010-4500-0
|
| 26 |
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, Tavan Janvilisri. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma. International Journal of Genomics 2015; 2015: 1 doi: 10.1155/2015/179528
|
| 27 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 28 |
Amir A Rahnemai-Azar, Pallavi Pandey, Ihab Kamel, Timothy M Pawlik. Monitoring Outcomes in Intrahepatic Cholangiocarcinoma Patients Following Hepatic Resection. Hepatic Oncology 2016; 3(4): 223 doi: 10.2217/hep-2016-0009
|
| 29 |
Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver International 2019; 39(S1): 108 doi: 10.1111/liv.14090
|
| 30 |
Waraporn Saentaweesuk, Atit Silsirivanit, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Chawalit Pairojkul, Ubon Cha'on, Somsiri Indramanee, Somchai Pinlaor, Thidarut Boonmars, Norie Araki, Chaisiri Wongkham. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. Clinica Chimica Acta 2018; 477: 66 doi: 10.1016/j.cca.2017.12.005
|
| 31 |
Fan Lin, Zongming Eric Chen, Hanlin L. Wang. Utility of Immunohistochemistry in the Pancreatobiliary Tract. Archives of Pathology & Laboratory Medicine 2015; 139(1): 24 doi: 10.5858/arpa.2014-0072-RA
|
| 32 |
Peti Thuwajit, Watinee Chawengrattanachot, Chanitra Thuwajit, Banchob Sripa, Felicity E. B. May, Bruce R. Westley, Nisana N. Tepsiri, Anucha Paupairoj, Siri Chau‐in. Increased TFF1 trefoil protein expression in Opisthorchis viverrini‐associated cholangiocarcinoma is important for invasive promotion. Hepatology Research 2007; 37(4): 295 doi: 10.1111/j.1872-034X.2007.00045.x
|
| 33 |
Katherine K. Benson, Ankur Sheel, Shafia Rahman, Ashwini Esnakula, Ashish Manne. Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. Cancers 2023; 15(2): 433 doi: 10.3390/cancers15020433
|
| 34 |
Anthony T. Ruys, Bas Groot Koerkamp, Jimme K. Wiggers, Heinz-Josef Klümpen, Fiebo J. ten Kate, Thomas M. van Gulik. Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis. Annals of Surgical Oncology 2014; 21(2): 487 doi: 10.1245/s10434-013-3286-x
|
| 35 |
Shiv Ram Krishn, Koelina Ganguly, Sukhwinder Kaur, Surinder K Batra. Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view. Carcinogenesis 2018; 39(5): 633 doi: 10.1093/carcin/bgy019
|
| 36 |
Wichuda Bamrungphon, Nalinee Prempracha, Nophawan Bunchu, Samreung Rangdaeng, Trichak Sandhu, Songphol Srisukho, Chanchai Boonla, Sopit Wongkham. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Letters 2007; 247(2): 301 doi: 10.1016/j.canlet.2006.05.007
|
| 37 |
|
| 38 |
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, Isabella Lurje, Cornelius Engelmann, Dominik P. Modest, Uwe Pelzer, Felix Krenzien, Nathanael Raschzok, Christian Benzing, Igor M. Sauer, Sebastian Stintzing, Frank Tacke, Wenzel Schöning, Moritz Schmelzle, Johann Pratschke, Georg Lurje. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers 2022; 14(4): 1026 doi: 10.3390/cancers14041026
|
| 39 |
Rajagopal Aravalli, Clifford Steer. Immune-Mediated Therapies for Liver Cancer. Genes 2017; 8(2): 76 doi: 10.3390/genes8020076
|
| 40 |
Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Thaweesak Chieochansin, Naravat Poungvarin, Sopit Wongkham, Mutita Junking, Pa-thai Yenchitsomanus. Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85747-9
|
| 41 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8): 722 doi: 10.2174/0115680266290367240130054142
|